Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Zydus Pharmaceuticals (USA) Inc

US Class II Ongoing · initiated 2025-09-03

CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

Zydus Pharmaceuticals (USA) Inc

US Class II Ongoing · initiated 2025-09-03

CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

Zydus Pharmaceuticals (USA) Inc

US Class II Ongoing · initiated 2025-09-03

CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

Zydus Pharmaceuticals (USA) Inc

US Class II Ongoing · initiated 2025-09-03

CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

SUN PHARMACEUTICAL INDUSTRIES INC

US Class II Ongoing · initiated 2025-09-03

Failed Dissolution Specifications-Out of Specification (OOS) observation for sulphate in Sodium Tartrate Dihydrate used for the production of Mertiatide.

Glenmark Pharmaceuticals Inc., USA

US Class II Ongoing · initiated 2025-09-03

Failed Impurities/Degradation Specifications

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

US Class II Ongoing · initiated 2025-09-02

Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected…

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

US Class II Ongoing · initiated 2025-09-02

Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected…

AvKARE

US Class II Ongoing · initiated 2025-09-02

Failed Content Uniformity Specifications

PMS-Busulfan 6 mg/mL

Canada Type III Ongoing · initiated 2025-09-02

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Fagron Compounding Services

US Class II Ongoing · initiated 2025-08-29

Lack of Assurance of Sterility

PMS-SUMATRIPTAN

Canada Type II Ongoing · initiated 2025-08-29

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Ascend Laboratories, LLC

US Class II Ongoing · initiated 2025-08-28

Superpotent drug

Granules Pharmaceuticals Inc.

US Class III Ongoing · initiated 2025-08-28

Failed Impurities/Degradation Specifications:

Granules Pharmaceuticals Inc.

US Class III Ongoing · initiated 2025-08-28

Failed Impurities/Degradation Specifications:

Granules Pharmaceuticals Inc.

US Class III Ongoing · initiated 2025-08-28

Failed Impurities/Degradation Specifications:

Granules Pharmaceuticals Inc.

US Class III Ongoing · initiated 2025-08-28

Failed Impurities/Degradation Specifications:

Granules Pharmaceuticals Inc.

US Class III Ongoing · initiated 2025-08-28

Failed Impurities/Degradation Specifications:

Green Lumber Holdings, LLC

US Class I Ongoing · initiated 2025-08-28

Marketed without an Approved NDA/ANDA: FDA analysis found this product to contain tadalafil

Atlantic Management Resources Ltd.

US Class II Ongoing · initiated 2025-08-27

cGMP violations

Zydus Pharmaceuticals (USA) Inc

US Class II Ongoing · initiated 2025-08-27

Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity.

Amerisource Health Services LLC

US Class II Ongoing · initiated 2025-08-27

Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a…

Amerisource Health Services LLC

US Class II Ongoing · initiated 2025-08-27

Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a…

Amerisource Health Services LLC

US Class II Ongoing · initiated 2025-08-27

Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a…

Amerisource Health Services LLC

US Class II Ongoing · initiated 2025-08-27

Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a…